K.T. ROMFARM COMPANY S.R.L. (manufacturing and primary packaging of medicinal product; physico-chemical control and batch release; secondary packaging and biological and microbiological control of medicinal product)

The drug is prescribed to women in postmenopause for the treatment of locally advanced or metastatic estrogen receptor-positive breast cancer. It may be used as monotherapy or in combination with palbociclib.

Dosage form: solution for injection

ATC: L02BA03